Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Form 8.5 (EPT/NON-RI)

19 Jul 2024 14:36

RNS Number : 1314X
Cavendish Securities PLC
19 July 2024
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Cavendish Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Plant Health Care Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Plant Health Care Plc

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

18/07/2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ORD 2p

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-61060

 

 

 

-0.02

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-61060

 

 

-0.02

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ORD 1p

 

 

 

 

 

Sell

100000

 

 

 

 

 

 

 

 

8.80

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8.80

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

19/07/2024

Contact name:

Francesca Mason

Telephone number:

020 3772 4644

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOUKOORSAUBAAR
Date   Source Headline
1st Sep 20118:00 amRNSStatement re Jeremy Scudamore
22nd Aug 201110:00 amRNSPosting of Interim Report
19th Aug 201110:30 amRNSBLOCK LISTING SIX-MONTHLY RETURN
17th Aug 201110:40 amRNSAdditional Listing and Directors' Shareholdings
15th Aug 20117:00 amRNSHalf Yearly Report
28th Jul 20114:30 pmRNSHolding(s) in Company
1st Jun 20115:00 pmRNSHolding(s) in Company
27th May 20113:00 pmRNSHolding(s) in Company
26th May 20117:00 amRNSTrading Update
14th Apr 20112:51 pmRNSResult of AGM
7th Apr 201110:00 amRNSHolding(s) in Company
21st Mar 201112:00 pmRNSAnnual Financial Report and Notice of AGM
1st Mar 201110:15 amRNSTotal Voting Rights
24th Feb 201110:30 amRNSReplacement Director/PDMR Shareholding
23rd Feb 20111:30 pmRNSDirector/PDMR Shareholding
22nd Feb 201112:15 pmRNSDirector/PDMR Shareholding
21st Feb 20117:01 amRNSFinal Results
18th Feb 20113:00 pmRNSBlocklisting Interim Review
14th Jan 20117:00 amRNSDisposal and Trading Update
12th Jan 20115:30 pmRNSHolding(s) in Company
15th Dec 20102:30 pmRNSHolding(s) in Company
1st Nov 201012:59 pmRNSTotal Voting Rights
25th Oct 20109:34 amRNSLicensing Agreement with XS Inc
1st Oct 20103:00 pmRNSTotal Voting Rights
9th Sep 20107:00 amRNSAgreement with Germains Seed Technology
1st Sep 201010:30 amRNSTotal Voting Rights
24th Aug 20103:30 pmRNSPosting of Interim Report
19th Aug 201012:30 pmRNSBlocklisting Interim Review
18th Aug 201010:15 amRNSAdditional Listing
16th Aug 20107:00 amRNSHalf Yearly Report
26th Jul 20107:00 amRNSAgreement with Syngenta Crop Protection Inc.
12th Jul 201012:30 pmRNSHolding(s) in Company
1st Jul 201010:05 amRNSHolding(s) in Company
1st Jul 201010:00 amRNSHolding(s) in Company
30th Jun 20104:45 pmRNSTotal Voting Rights
29th Jun 20109:30 amRNSHolding(s) in Company
16th Jun 201011:20 amRNSTrading Update
28th May 20107:00 amRNSSale of PHC Reclamation Inc.
10th May 20107:00 amRNSMyconate Collaboration with Brazilian Government
6th May 20107:00 amRNSMyconate Agreement with Legacy Seeds Inc
30th Apr 20109:30 amRNSTotal Voting Rights
28th Apr 20109:30 amRNSAdditional Listing
28th Apr 20107:00 amRNSPatent Application for AirStrike programme
26th Apr 20107:00 amRNSMyconate IP Agreement with Bayer CropScience
21st Apr 20106:00 pmRNSVesting of Shares under LTIP
20th Apr 20107:00 amRNSHarpin agreement with Plant Foods Inc.
15th Apr 20105:00 pmRNSResult of AGM
22nd Mar 20107:00 amRNSPatent Protection Application
15th Mar 20103:30 pmRNSDirector/PDMR Shareholding
8th Mar 201012:45 pmRNSPublication of Annual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.